Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Difficult KOLs: How to overcome challenges, find success and gain access
Summary
In this episode, Andrea Johnson joins Tom Caravela to delve into effective strategies for Medical Science Liaisons. They explore the value of Key Opinion Leaders (KOLs), emphasizing the importance of pre-call planning and preparation. Andrea shares techniques for building strong connections with KOLs and utilizing internal resources effectively. The conversation covers networking tips, the significance of text relationships, and handling challenging interactions. They discuss overcoming negative experiences and the importance of respect in professional relationships. The episode concludes with key takeaways and a call to action for listeners.
My guest today, is Andrea Johnson, National Director, MSLs. Andrea discusses how to overcome challenges, find success and gain access to difficult KOLs
Andrea shares…
👉 Interesting stories about difficult KOLs
👉 Some effective strategies and best practices for turning around difficult KOLs
👉 Practical tips for KOL relationship building
👉 How important pre-call planning is as a practice
👉 What ideas or creative strategies she has seen work for gaining access with tough KOLs
Medical Science Liaisons, Key Opinion Leaders, pre-call planning, KOL relationship building, overcoming challenges
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO